|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
1,784
-1.6%
10.67
USD 19,035
|
1,784
-1.6%
|
10.67
|
USD 19,035
|
|
|
2024-12-12 |
2024-12-11 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
21,787
-0.5%
20.23
USD 440,751
|
21,787
-0.5%
|
20.23
|
USD 440,751
|
|
|
2024-12-12 |
2024-12-11 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
21,787
-0.5%
20.23
USD 440,751
|
21,787
-0.5%
|
20.23
|
USD 440,751
|
|
|
2024-12-12 |
2024-12-10 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
22,935
-0.5%
20.77
USD 476,360
|
22,935
-0.5%
|
20.77
|
USD 476,360
|
|
|
2024-12-12 |
2024-12-10 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
22,935
-0.5%
20.77
USD 476,360
|
22,935
-0.5%
|
20.77
|
USD 476,360
|
|
|
2024-12-03 |
2024-12-03 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
11,703
-7.5%
20.15
USD 235,786
|
11,703
-7.5%
|
20.15
|
USD 235,786
|
|
|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
4,088
-2.5%
20.26
USD 82,834
|
4,088
-2.5%
|
20.26
|
USD 82,834
|
|
|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
5,000
-6.3%
20.00
USD 99,978
|
5,000
-6.3%
|
20.00
|
USD 99,978
|
|
|
2024-12-03 |
2024-11-29 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
100
-0.1%
20.00
USD 2,000
|
100
-0.1%
|
20.00
|
USD 2,000
|
|
|
2024-12-03 |
2024-11-29 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
1,000
-1.3%
19.97
USD 19,970
|
1,000
-1.3%
|
19.97
|
USD 19,970
|
|
|
2024-11-13 |
2024-11-13 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
2,700
-1.7%
20.04
USD 54,109
|
2,700
-1.7%
|
20.04
|
USD 54,109
|
|
|
2024-11-13 |
2024-11-11 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
1,409
-0.9%
20.01
USD 28,191
|
1,409
-0.9%
|
20.01
|
USD 28,191
|
|
|
2024-11-13 |
2024-11-11 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
8,637
-10.5%
19.98
USD 172,562
|
8,637
-10.5%
|
19.98
|
USD 172,562
|
|
|
2024-11-06 |
2024-11-06 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
2,745
-1.6%
19.32
USD 53,024
|
2,745
-1.6%
|
19.32
|
USD 53,024
|
|
|
2024-11-06 |
2024-11-06 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
9,554
-5.4%
18.71
USD 178,752
|
9,554
-5.4%
|
18.71
|
USD 178,752
|
|
|
2024-11-06 |
2024-11-05 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
5,171
-2.8%
18.18
USD 94,006
|
5,171
-2.8%
|
18.18
|
USD 94,006
|
|
|
2024-11-06 |
2024-11-04 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
749
-0.4%
18.02
USD 13,498
|
749
-0.4%
|
18.02
|
USD 13,498
|
|
|
2024-10-18 |
2024-10-16 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
600
-0.3%
18.00
USD 10,800
|
600
-0.3%
|
18.00
|
USD 10,800
|
|
|
2024-09-30 |
2024-09-26 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
847
-0.7%
16.00
USD 13,552
|
847
-0.7%
|
16.00
|
USD 13,552
|
|
|
2024-09-10 |
2024-09-09 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
3,195
-4.0%
14.97
USD 47,832
|
3,195
-4.0%
|
14.97
|
USD 47,832
|
|
|
2024-09-10 |
2024-09-09 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
1,904
-1.5%
15.07
USD 28,690
|
1,904
-1.5%
|
15.07
|
USD 28,690
|
|
|
2024-09-10 |
2024-09-09 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
2,642
-1.4%
15.09
USD 39,862
|
2,642
-1.4%
|
15.09
|
USD 39,862
|
|
|
2024-09-10 |
2024-09-06 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
399
-0.3%
15.19
USD 6,063
|
399
-0.3%
|
15.19
|
USD 6,063
|
|
|
2024-09-10 |
2024-09-06 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
600
-0.3%
15.24
USD 9,141
|
600
-0.3%
|
15.24
|
USD 9,141
|
|
|
2024-08-20 |
2024-08-16 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
502
-0.4%
16.70
USD 8,382
|
502
-0.4%
|
16.70
|
USD 8,382
|
|
|
2024-08-20 |
2024-08-16 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
26,595
-16.9%
16.26
USD 432,419
|
26,595
-16.9%
|
16.26
|
USD 432,419
|
|
|
2024-07-16 |
2024-07-15 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
1,600
-0.5%
17.81
USD 28,497
|
1,600
-0.5%
|
17.81
|
USD 28,497
|
|
|
2024-07-16 |
2024-07-15 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
638
-0.3%
18.00
USD 11,484
|
638
-0.3%
|
18.00
|
USD 11,484
|
|
|
2024-07-16 |
2024-07-12 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
300
-0.1%
18.00
USD 5,400
|
300
-0.1%
|
18.00
|
USD 5,400
|
|
|
2024-07-16 |
2024-07-12 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
600
-0.3%
18.00
USD 10,800
|
600
-0.3%
|
18.00
|
USD 10,800
|
|
|
2024-07-10 |
2024-07-08 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
1,758
-2.1%
14.95
USD 26,282
|
1,758
-2.1%
|
14.95
|
USD 26,282
|
|
|
2024-06-14 |
2024-06-13 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
1,000
-0.3%
16.17
USD 16,174
|
1,000
-0.3%
|
16.17
|
USD 16,174
|
|
|
2024-05-20 |
2024-05-20 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
9,675
-4.8%
15.19
USD 146,944
|
9,675
-4.8%
|
15.19
|
USD 146,944
|
|
|
2024-05-20 |
2024-05-20 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
9,675
-4.8%
15.19
USD 146,944
|
9,675
-4.8%
|
15.19
|
USD 146,944
|
|
|
2024-05-20 |
2024-05-17 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
1,200
-0.4%
15.11
USD 18,129
|
1,200
-0.4%
|
15.11
|
USD 18,129
|
|
|
2024-05-20 |
2024-05-17 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
8,305
-4.0%
15.14
USD 125,751
|
8,305
-4.0%
|
15.14
|
USD 125,751
|
|
|
2024-05-20 |
2024-05-17 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
8,305
-4.0%
15.14
USD 125,751
|
8,305
-4.0%
|
15.14
|
USD 125,751
|
|
|
2024-05-20 |
2024-05-16 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
1,800
-0.5%
15.00
USD 27,000
|
1,800
-0.5%
|
15.00
|
USD 27,000
|
|
|
2024-05-20 |
2024-05-16 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
1,000
-0.5%
15.00
USD 15,000
|
1,000
-0.5%
|
15.00
|
USD 15,000
|
|
|
2024-05-20 |
2024-05-16 |
PS
Planned sale
|
Sethuraman Natarajan
Chief Scientific Officer
Officer
|
1,000
-0.5%
15.00
USD 15,000
|
1,000
-0.5%
|
15.00
|
USD 15,000
|
|
|
2024-05-16 |
2024-05-14 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
25,000
+37.1%
14.59
USD 364,673
|
25,000
+37.1%
|
14.59
|
USD 364,673
|
|
|
2024-05-10 |
2024-05-09 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
2,200
+3.4%
14.25
USD 31,341
|
2,200
+3.4%
|
14.25
|
USD 31,341
|
|
|
2024-05-10 |
2024-05-08 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
2,276
+3.6%
14.04
USD 31,965
|
2,276
+3.6%
|
14.04
|
USD 31,965
|
|
|
2024-04-10 |
2024-04-08 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
2,600
+4.3%
13.57
USD 35,290
|
2,600
+4.3%
|
13.57
|
USD 35,290
|
|
|
2024-04-01 |
2024-03-28 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
1,512
+2.6%
13.75
USD 20,794
|
1,512
+2.6%
|
13.75
|
USD 20,794
|
|
|
2024-03-26 |
2024-03-26 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
2,750
+4.9%
13.64
USD 37,509
|
2,750
+4.9%
|
13.64
|
USD 37,509
|
|
|
2024-03-26 |
2024-03-25 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
3,180
+6.0%
13.36
USD 42,472
|
3,180
+6.0%
|
13.36
|
USD 42,472
|
|
|
2024-03-26 |
2024-03-22 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
3,118
+6.3%
13.76
USD 42,901
|
3,118
+6.3%
|
13.76
|
USD 42,901
|
|
|
2024-03-21 |
2024-03-21 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
704
+1.4%
13.24
USD 9,318
|
704
+1.4%
|
13.24
|
USD 9,318
|
|
|
2024-03-21 |
2024-03-20 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
1,128
+2.4%
12.66
USD 14,281
|
1,128
+2.4%
|
12.66
|
USD 14,281
|
|
|
2024-03-21 |
2024-03-19 |
B
Purchase
|
KIM PETER S
Non-Executive Director
|
900
+1.9%
12.66
USD 11,397
|
900
+1.9%
|
12.66
|
USD 11,397
|
|
|
2024-03-08 |
2024-03-06 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
4,086
-5.2%
12.31
USD 50,285
|
4,086
-5.2%
|
12.31
|
USD 50,285
|
|
|
2024-03-08 |
2024-03-06 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
1,826
-1.3%
12.32
USD 22,499
|
1,826
-1.3%
|
12.32
|
USD 22,499
|
|
|
2024-02-20 |
2024-02-15 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
1,000
-0.4%
15.00
USD 15,000
|
1,000
-0.4%
|
15.00
|
USD 15,000
|
|
|
2024-01-18 |
2024-01-16 |
PS
Planned sale
|
Doshi Dipal
CEO
Executive Director
|
1,000
-0.4%
15.99
USD 15,990
|
1,000
-0.4%
|
15.99
|
USD 15,990
|
|
|
2023-12-26 |
2023-12-26 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
94
-0.2%
16.67
USD 1,567
|
94
-0.2%
|
16.67
|
USD 1,567
|
|
|
2023-12-26 |
2023-12-22 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
3,677
-6.9%
16.48
USD 60,611
|
3,677
-6.9%
|
16.48
|
USD 60,611
|
|
|
2023-12-26 |
2023-12-22 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
6,529
-10.9%
15.24
USD 99,513
|
6,529
-10.9%
|
15.24
|
USD 99,513
|
|
|
2023-12-26 |
2023-12-21 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
2,200
-4.2%
15.07
USD 33,155
|
2,200
-4.2%
|
15.07
|
USD 33,155
|
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Doshi Dipal
President and CEO
Executive Director
|
1,000
-0.4%
15.00
USD 15,000
|
1,000
-0.4%
|
15.00
|
USD 15,000
|
|
|
2023-11-13 |
2023-11-13 |
PS
Planned sale
|
Doshi Dipal
President and CEO
Executive Director
|
1,000
-0.4%
16.23
USD 16,230
|
1,000
-0.4%
|
16.23
|
USD 16,230
|
|
|
2023-10-19 |
2023-10-17 |
PS
Planned sale
|
Doshi Dipal
President and CEO
Executive Director
|
1,000
-0.4%
15.00
USD 15,000
|
1,000
-0.4%
|
15.00
|
USD 15,000
|
|
|
2023-09-15 |
2023-09-13 |
PS
Planned sale
|
Doshi Dipal
President and CEO
Executive Director
|
1,000
-0.4%
15.00
USD 15,000
|
1,000
-0.4%
|
15.00
|
USD 15,000
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
Dowden Nathan J
Chief Operating Officer
Officer
|
59
-0.1%
14.01
USD 826
|
59
-0.1%
|
14.01
|
USD 826
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
Dowden Nathan J
Chief Operating Officer
Officer
|
913
-1.9%
13.43
USD 12,263
|
913
-1.9%
|
13.43
|
USD 12,263
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
21
-0.1%
14.00
USD 294
|
21
-0.1%
|
14.00
|
USD 294
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
871
-2.1%
13.46
USD 11,728
|
871
-2.1%
|
13.46
|
USD 11,728
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
46
-0.1%
14.03
USD 645
|
46
-0.1%
|
14.03
|
USD 645
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
904
-1.8%
13.45
USD 12,161
|
904
-1.8%
|
13.45
|
USD 12,161
|
|
|
2023-08-16 |
2023-08-14 |
PS
Planned sale
|
Doshi Dipal
President and CEO
Executive Director
|
1,000
-0.5%
15.67
USD 15,671
|
1,000
-0.5%
|
15.67
|
USD 15,671
|
|
|
2023-08-04 |
2023-08-04 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
6,898
-20.3%
14.14
USD 97,521
|
6,898
-20.3%
|
14.14
|
USD 97,521
|
|
|
2023-08-04 |
2023-08-03 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
9,464
-25.9%
14.74
USD 139,530
|
9,464
-25.9%
|
14.74
|
USD 139,530
|
|
|
2023-08-04 |
2023-08-02 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
68
-0.3%
16.82
USD 1,144
|
68
-0.3%
|
16.82
|
USD 1,144
|
|
|
2023-08-04 |
2023-08-02 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
1,000
-3.5%
16.01
USD 16,012
|
1,000
-3.5%
|
16.01
|
USD 16,012
|
|
|
2023-08-04 |
2023-08-02 |
PS
Planned sale
|
KREHER NERISSA
Chief Medical Officer
Officer
|
9,280
-24.8%
15.09
USD 140,013
|
9,280
-24.8%
|
15.09
|
USD 140,013
|
|
